Pharmaceutical Product Monograph: Cloxacillin Sodium (250 mg, 500 mg, 1 g)
In the pharmaceutical industry, Cloxacillin is a parenteral, semi-synthetic Penicillinase-Resistant Penicillin (also known as an Antistaphylococcal Penicillin). As a pharmacist and manufacturer, I view this molecule as the “Staphylococcal Specialist”—it is technically designed with a bulky side chain that physically prevents bacterial enzymes (penicillinases) from breaking the drug’s beta-lactam ring.
At your WHO-GMP facility in Mumbai, Cloxacillin is a vital SKU for Surgery, Dermatology, and Orthopedic portfolios. It is the first-line defense for severe infections where Staphylococcus aureus is the confirmed or suspected pathogen.
Therapeutic Profile: Primary Indications
Cloxacillin injection is indicated for the treatment of severe infections caused by penicillinase-producing Staphylococci.
| Indication | Clinical Context | Technical Rationale |
| Skin & Soft Tissue | Cellulitis / Abscesses | Gold Standard: Highly effective against “Staph” infections of the skin, including carbuncles and infected wounds. |
| Surgical Prophylaxis | Orthopedic / Vascular | Used to prevent post-operative infections, particularly in procedures involving prosthetic implants. |
| Septicemia | Bloodstream Infection | Used when the blood infection is traced back to a staphylococcal source (e.g., infected IV lines). |
| Osteomyelitis | Bone & Joint Infection | Penetrates bone tissue effectively to treat bacterial arthritis and bone marrow infections. |
| Endocarditis | Staphylococcal | Used in high-dose IV regimens to treat infections of the heart valves. |
Mechanism: Steric Hindrance against Beta-Lactamase
Cloxacillin works by sabotaging the bacterial cell wall, but with a unique structural “shield”:
The Bulky Side Chain: Most penicillins are destroyed by an enzyme called Beta-Lactamase (Penicillinase). Cloxacillin has a bulky “isoxazolyl” side chain that technically blocks the enzyme from reaching the beta-lactam ring.
PBP Binding: The drug binds to Penicillin-Binding Proteins (PBPs) on the bacterial cell wall.
Cross-linking Blockade: It prevents the final step of peptidoglycan synthesis, leaving the bacterial cell wall weak and unstable.
Bacterial Lysis: The bacteria burst due to internal osmotic pressure, leading to cell death.
The Pharmacist’s “Technical Warning”
The “MRSA” Gap: As a pharmacist, I must emphasize that Cloxacillin is not effective against Methicillin-Resistant Staphylococcus aureus (MRSA). If MRSA is suspected, Vancomycin is technically required.
The “Empty Stomach” Rule: While we are discussing the injection, if a patient transitions to the oral form, it must be taken 1 hour before or 2 hours after meals, as food significantly interferes with absorption.
Neurotoxicity: High doses in patients with Renal Impairment can lead to cerebral irritation, resulting in convulsions or twitching.
Hypersensitivity: Like all penicillins, there is a risk of severe Anaphylaxis. A skin sensitivity test (TST) is mandatory before the first dose.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Aseptic Filling” USP: Cloxacillin Sodium is highly sensitive to heat and moisture. On your digital marketplace, highlight your Vacuum-Sealed Aseptic Filling Line. This ensures the powder remains white and free-flowing, preventing the “clumping” often seen in lower-quality generics.
The “Ampicillin-Cloxacillin” FDC: Many B2B clients in Africa and SE Asia request the Ampiclox (Ampicillin + Cloxacillin) combination. Offering this as a pre-mixed 500 mg or 1 g vial is a major technical advantage for broad-spectrum empirical use in pediatric wards.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cloxacillin 250 mg and 500 mg vials to support your registration in international B2B tenders for surgery and infectious disease.